Chengchao Shou

Title: The Innovations of Inventor Chengchao Shou

Introduction: Chengchao Shou is a prominent inventor based in Beijing, China, known for his significant contributions to the field of anti-angiogenesis. With a total of 2 patents to his name, he has made notable advancements in the treatment of diseases related to angiogenesis, particularly in cancer therapy. His work combines cutting-edge research with practical applications aimed at improving patient outcomes.

Latest Patents: Chengchao Shou's most recent patents include two groundbreaking inventions. The first patent, titled "Peptide for Anti-Angiogenesis and Use Thereof," focuses on a specific peptide that is effective in treating angiogenesis-related diseases. This invention encompasses the peptide itself, a polynucleotide that codes for the peptide, as well as various pharmaceutical compositions that can be utilized in treating tumors through anti-angiogenesis mechanisms.

The second patent, "Antagonist Peptides to VEGF Receptor Flt-1," introduces a polypeptide or its pharmacologically acceptable salt, which contains sequences designed to target angiogenic diseases. This invention also includes a polynucleotide that encodes the polypeptide, offering potential applications in gene therapy for diseases such as solid tumors.

Career Highlights: As an inventor at the Beijing Institute for Cancer Research, Chengchao Shou has developed innovations that emphasize the therapeutic potential of peptides in combating angiogenesis. His research and patent filings reflect a deep commitment to advancing the understanding and treatment of cancer, showcasing his expertise in molecular biology and pharmacology.

Collaborations: Throughout his career, Chengchao Shou has collaborated with esteemed colleagues, including Yahui Su and Qin Feng. These partnerships have enabled him to expand the scope of his research and foster collaborative efforts in the field of cancer research and innovative therapeutic approaches.

Conclusion: Chengchao Shou represents a vital player in the realm of medical innovations, with patents that hold promise for treating serious health conditions. As research continues to evolve, his work at the Beijing Institute for Cancer Research paves the way for future developments in anti-angiogenesis therapies, offering hope to many affected by angiogenesis-related diseases. His contributions underscore the importance of innovation in improving health outcomes and advancing medical science.